Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Interventions in Aging|September 15, 2009
A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patientsDimitrios A Karagiannis, Vasilios Soublis, Artemios Kandarakis
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|April 25, 2009
Large subretinal haemorrhage following change from intravitreal bevacizumab to ranibizumabDimitrios A Karagiannis, Panagiotis Mitropoulos, Ioannis D Ladas
Ophthalmology and Therapy|June 22, 2025
Safety Evaluation of Bilateral Same-Day Intravitreal Injection of FaricimabMichael D Karampelas, Irini P Chatziralli, Dimitrios A Karagiannis
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complexIlias Georgalas, Alexandros A Rouvas, Dimitrios A Karagiannis, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 14, 2011
Recurrence of macular edema in retinal vein occlusions after treatment with intravitreal ranibizumab (Lucentis)Dimitrios A Karagiannis, Michael D Karampelas, Vasileios M Soumplis, et al.
Retina (Philadelphia, Pa.)|March 17, 2009
Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2,000 injectionsIoannis D Ladas, Dimitrios A Karagiannis, Alexandros A Rouvas, et al.
Journal of Cataract and Refractive Surgery|March 23, 2011
Bilateral central serous retinopathy following laser in situ keratomileusis for myopiaVasileios G Peponis, Spyridon E Chalkiadakis, Spyridon D Nikas, et al.
Clinical Interventions in Aging|January 8, 2010
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?Dimitrios A Karagiannis, Ioannis D Ladas, Efstratios Parikakis, et al.
Pageof 2